Dennis Podlesak's Net Worth
$3.59 Million
Who is Dennis Podlesak?
Dennis Podlesak has an estimated net worth of $3.59 Million. This is based on reported shares across multiple companies, which include Alliqua BioMedical, Inc., Syndax Pharmaceuticals Inc, AVANIR PHARMACEUTICALS, INC., Regado Biosciences Inc, and DOV PHARMACEUTICAL INC.
SEC CIK
Dennis Podlesak's CIK is 0001314595
Past Insider Trading and Trends
2006 was Dennis Podlesak's most active year for acquiring shares with 4 total transactions. Dennis Podlesak's most active month to acquire stocks was the month of January. 2022 was Dennis Podlesak's most active year for disposing of shares, totalling 6 transactions. Dennis Podlesak's most active month to dispose stocks was the month of August. 2022 saw Dennis Podlesak paying a total of $498,307.48 for 110,815 shares, this is the most they've acquired in one year. In 2022 Dennis Podlesak cashed out on 157,630 shares for a total of $1,897,987.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alliqua BioMedical, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 85.25K |
—
|
—
| 85.25K |
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.55% | 34K |
—
|
—
| 141.76K |
Feb 7
| |||
Form 4
| +42.24% | 32K |
—
|
—
| 107.76K |
Feb 2
| |||
Form 4
|
—
|
0
|
$15.20 | -$1,399,680.05 | 75.76K |
Scheduled
|
Sep 15 - Sep 16
| ||
Form 4
| +73.12% | 32K |
—
|
—
| 75.76K |
Feb 2
| |||
Form 4
| +1.07% | 463 |
—
|
—
| 43.76K |
Oct 5
| |||
Form 4
| +47.62% | 13.97K |
$14.11 | $197,077.16 | 43.3K |
Apr 22
| |||
Form 4
|
∞
| 29.33K |
—
|
—
| 29.33K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AVANIR PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.40% | 28.9K |
—
|
—
| 336.39K |
Feb 12
| |||
Form 4
| +14.48% | 38.9K |
—
|
—
| 307.49K |
Feb 14
| |||
Form 4
| +12.57% | 30K |
—
|
—
| 268.59K |
Feb 16
| |||
Form 4
| +14.38% | 30K |
—
|
—
| 238.59K |
Feb 8
| |||
Form 4
| +23.73% | 40K |
—
|
—
| 208.59K |
Feb 18
| |||
Form 4
| +55.25% | 60K |
—
|
—
| 168.59K |
Feb 19
| |||
Form 4
| +110.12% | 56.91K |
—
|
—
| 108.59K |
Feb 21
| |||
Form 4
| +595.13% | 44.25K |
—
|
—
| 51.68K |
Mar 1
| |||
Form 4
| +15.54% | 1K |
$9.90 | $9,902.00 | 7.43K |
May 31
| |||
Form 4
|
∞
| 6.43K |
—
|
—
| 6.43K |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Regado Biosciences Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DOV PHARMACEUTICAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |